| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 9 |
| 1 | BENDAMUSTINE HCL | 4 |
| 2 | VALSARTAN | 4 |
| 3 | VALSARTAN ORAL | 4 |
| 4 | ENALAPRIL | 3 |
| 5 | RAMIPRIL | 3 |
| 6 | ZANUBRUTINIB | 2 |
| 7 | AAMLODIPINE AND OLMESARTAN MEDOXOMIL | 1 |
| 8 | ACYCLOVIR | 1 |
| 9 | AMLODIPINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AAMLODIPINE AND OLMESARTAN MEDOXOMIL | 1 | 0.0049 |
| 1 | ZANUBRUTINIB | 2 | 0.0004 |
| 2 | SUGAMMADEX | 1 | 0.0004 |
| 3 | BENDAMUSTINE HCL | 4 | 0.0003 |
| 4 | IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE | 1 | 0.0002 |
| 5 | IMMUNE GLOBULIN INFUSION (HUMAN) | 1 | 0.0001 |
| 6 | ROCURONIUM BROMIDE | 1 | 0.0001 |
| 7 | ENALAPRIL | 3 | 0.0001 |
| 8 | RITUXIMAB | 9 | 0.0000 |
| 9 | RAMIPRIL | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 9 | 0.0000 |
| 2 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 3 | Angiotensin Converting Enzyme Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 4 | 0.0000 |
| 5 | Anti-IgE [EPC] | 1 | 0.0000 |
| 6 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |